Holen Sie sich die Stockscreener-App
56.64
0.33%
-0.19
Handel nachbörslich:
57.16
0.52
+0.92%
Schlusskurs vom Vortag:
$56.83
Offen:
$56.83
24-Stunden-Volumen:
746.58K
Relative Volume:
0.61
Marktkapitalisierung:
$1.63B
Einnahmen:
$911.98M
Nettoeinkommen (Verlust:
$145.42M
KGV:
11.41
EPS:
4.9642
Netto-Cashflow:
$78.48M
1W Leistung:
+6.11%
1M Leistung:
-3.38%
6M Leistung:
-28.16%
1J Leistung:
-61.27%
1-Tages-Spanne:
$55.60
$58.98
1-Wochen-Bereich:
$51.53
$58.98
52-Wochen-Spanne:
$48.30
$163.35
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
56.64 | 1.64B | 911.98M | 145.42M | 78.48M | 4.9642 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Call Transcript - MSN
Hedge funds view Inspire Medical (INSP) as one of the best small-cap healthcare stocks - MSN
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 3 - GuruFocus
INSP Maintained by Mizuho -- Price Target Lowered to $70 - GuruFocus
Inspire Medical Systems Outperforms Alternate Health in Key Metrics - National Today
Here's why you should add Inspire Medical stock to your portfolio now - MSN
INSP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why is Inspire (INSP) down 2.4% since last earnings report? - MSN
A Look at Inspire Medical Systems Inc (INSP) After 4.7% Decline -- GF Value $240.40 vs Price $54.02 - GuruFocus
(INSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Today's Analyst Ratings for INSP: Key Changes and Updates | INSP Stock News - GuruFocus
Stifel cuts Inspire Medical stock price target on reimbursement concerns By Investing.com - Investing.com Canada
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders - The National Law Review
Consider Including Inspire Medical Stock in Your Portfolio Right Now—Here's Why - Bitget
Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now - Zacks Investment Research
Inspire Medical Systems Inc. R (2DR.MU) Q1 FY2025 earnings call transcript - Yahoo Finance
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off - Yahoo Finance
Inspire Medical Systems, Inc. $INSP Shares Bought by Rheos Capital Works Inc. - MarketBeat
Inspire Medical (INSP) is Gaining Strength from Its Product Offering and Differentiation - Insider Monkey
Evercore Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $62 - Moomoo
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026 - Bitget
Aberdeen Group plc Acquires 64,561 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
A Look At Inspire Medical Systems (INSP) Valuation After CMS Reimbursement Clarity And Rising Hedge Fund Interest - Sahm
Inspire Medical Systems Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution - Moomoo
Inspire Medical Systems, Inc. (INSP) stock price, news, quote and history - Yahoo Finance Singapore
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines - Yahoo Finance Singapore
Inspire Medical Systems, Inc. $INSP Shares Bought by SG Americas Securities LLC - marketbeat.com
Inspire Medical Systems, Inc. $INSP Stock Position Increased by Banque Pictet & Cie SA - MarketBeat
MMSI Expands Oncology Offering With View Point Medical Acquisition - TradingView — Track All Markets
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo Finance
Inspire Medical Systems (INSP) Valuation Reset After Share Price Weakness Attracts Fresh Fundamental Scrutiny - Yahoo Finance
Is Inspire Medical Systems (INSP) Attractive After A 67% One-Year Share Price Slump? - Yahoo Finance
Hedge Funds View Inspire Medical (INSP) as One of the Best Small-Cap Healthcare Stocks - Insider Monkey
JPMorgan Chase & Co. Sells 301,067 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
JP Morgan Downgrades Inspire Medical Systems (INSP) - MSN
Inspire Medical Systems stock hits 52-week low at 48.76 USD By Investing.com - Investing.com South Africa
Inspire Medical Systems stock hits 52-week low at 48.76 USD - Investing.com Australia
Aug Volume: Is Inspire Medical Systems Inc benefiting from interest rate changesPortfolio Value Report & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Is It Time To Reassess Inspire Medical Systems (INSP) After Its Steep Multi‑Year Share Price Slump - Sahm
Inspire Medical Systems Hits New 52-Week Low at $48.78 - Markets Mojo
Responsive Playbooks and the INSP Inflection - Stock Traders Daily
Inspire Medical Systems (NYSE:INSP) Sets New 12-Month LowHere's Why - MarketBeat
Trend Review: Can Inspire Medical Systems Inc deliver consistent EPS growthPortfolio Return Report & High Conviction Investment Ideas - baoquankhu1.vn
Growth Value: Is Inspire Medical Systems Inc stock influenced by commodity prices2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn
Inspire Medical Systems Hits New 52-Week Low at $50.00 - Markets Mojo
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):